Inclusion health: working with injecting drug users living with wounds with Q&A

Dr Jemell Geraghty, Nurse Consultant Tissue Viability has worked in primary and secondary wound care services. While working full time she undertook a qualitative study exploring the experiences of injecting drug users living with leg ulceration: a narrative inquiry using diaries and semi- structured interviews: she was awarded a Professional Doctorate in Health Research (DHRes) from the University of Hertfordshire in 2018. Currently Jemell is leading a new wound-clinic pilot in central London for the provision of specialist wound care for people experiencing homelessness and those with a history of addiction. In 2019 she has been appointed as Visiting Clinical Teaching & Module Lead for Tissue Viability at Kings College, Florence Nightingale School of Nursing, Midwifery & Palliative Care London. Dr Geraghty sits on the editorial board for the British Journal of Nursing, Tissue Viability panel and has been involved with publishing and presenting on a national and international level. Dr Geraghty is passionate about inclusion health, nursing care and patient experience. Key points for discussion: • Background to injecting drug use and leg ulceration: a qualitative study • Review of current practice • Stigma associated with injecting drug use and leg ulceration – key findings • Moving forward: inclusion health and wound care